Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00726_DB01211_nanopub.RAHU5rGUcbEi2HVkCtwkQZeKziH3V-w450IknvOiD9wvE#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00726_DB01211 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00726_DB01211 label "DDI between Trimipramine and Clarithromycin - Additive QTc-prolongation may occur, increasing the risk of serious ventricular arrhythmias. Clarithromycin, a strong CYP3A4 inhibitor, may also decrease the metabolism and clearance of Trimipramine, a CYP3A4 substrate. Concomitant therapy should be used with caution. [drugbank_resource:DB00726_DB01211]" assertion.
- drugbank_resource:DB00726_DB01211 identifier "drugbank_resource:DB00726_DB01211" assertion.
- drugbank_resource:DB00726_DB01211 title "DDI between Trimipramine and Clarithromycin - Additive QTc-prolongation may occur, increasing the risk of serious ventricular arrhythmias. Clarithromycin, a strong CYP3A4 inhibitor, may also decrease the metabolism and clearance of Trimipramine, a CYP3A4 substrate. Concomitant therapy should be used with caution." assertion.
- drugbank:DB00726 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00726_DB01211 assertion.
- drugbank:DB01211 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00726_DB01211 assertion.